The Chartis Group, a portfolio company of Riordan, Lewis & Haden, has been sold to Audax Private Equity

Lincoln worked closely with shareholders and management to find the right partner for the business to continue its growth trajectory. This was a global advisory engagement providing transaction expertise and managing the preparatory, marketing, negotiating, and diligence phases of the process.

The Chartis Group is a mission-based, values-driven firm and a leading provider of comprehensive advisory and analytics services to the healthcare industry. Since inception, the company’s unyielding mission has been to materially improve the delivery of healthcare in the world. Chartis provides a comprehensive, cross-functional approach to clients’ most pressing and complex needs that is unmatched in the industry and has firmly established the Company as a nationally recognized, premium brand.

Ken Graboys, CEO of Chartis commented, “Lincoln’s deep understanding of our unique business model and culture and senior-level dedication throughout the process were instrumental in achieving a successful outcome with the right partner that allows Chartis to continue its growth trajectory and help our clients achieve unrivaled results.”

Rob Zielinski, Partner at Riordan, Lewis & Haden, added, “Lincoln’s global platform and access to key decision makers were critical in securing an exceptional new long-term partner for Chartis.”

The Chartis Group, a portfolio company of Riordan, Lewis & Haden, has been sold to Audax Private Equity
  • 2019
    Close Year
  • Business Services
    Industry
  • PE Backed
    Client Type
  • Financial | Domestic
    Transaction Type
  • USA
    Countries
Lincoln’s execution expertise and partnership approach with management created a highly efficient process, resulting in a great outcome for Chartis’ shareholders and management team.
Rob Zielinski
Partner at Riordan, Lewis & Haden

Meet our Senior Team